Medication info

Terbinafine Tablets (Terbinafine Hydrochloride)

Prescription medicationExpired
Ingredient · strength
Terbinafine Hydrochloride›Strength being verified
Manufacturer / importer
Aprogen Bio, Co., Ltd.
Appearance
White to off-white round tablets
Packaging
30, 100 tablets
Approval status
Expired

MFDS item code 200400953 · Approved 2004.09.30

This product's status changed to Expired on 2023.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of onychomycosis, cutaneous fungal infections (including tinea pedis), and tinea capitis in children
Who uses it
Adults · Children
Adult dosage
Administer terbinafine as 125 mg per dose twice daily or 250 mg per dose once daily. The duration of administration according to the condition is as follows: 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Usually administer for 6 weeks~3 months. In cases of infection of the fingernails or relatively small toenails, or in younger patients, the treatment period may be shortened to 3 months or less. A treatment period of 3 months is usually sufficient for toenail infections, but in some patients 6 months or longer may be required. The treatment period may be longer in patients with slow nail growth. For patients with creatinine clearance below 50 mL/min, reduce the daily dose by 1/2.
Children's dosage
Administer to children aged 2 years or older. Administration is not recommended for children under 2 years of age because there is no experience with use in this age group. Tinea capitis: 4 weeks 1) Body weight below 20 kg (under 5 years): Administer 62.5 mg per dose once daily. Because experience with use is limited, decide whether to administer by weighing the benefits and risks of treatment. 2) Body weight 20~40 kg (5~12 years): Administer 125 mg per dose once daily. 3) Body weight over 40 kg (over 12 years): Administer 250 mg per dose once daily.

Ingredients

Manufacturer
Aprogen Bio, Co., Ltd.

Efficacy & effects

Treatment of onychomycosis, cutaneous fungal infections (including tinea pedis), and tinea capitis in children

  • Dermatophyte infections of the skin
  • athlete's foot
  • tinea corporis
  • tinea cruris
  • nail fungal infections
  • tinea capitis
View approved original text

This medicine is used for the treatment of dermatophyte infections of the skin such as athlete's foot, tinea corporis, and tinea cruris, as well as nail fungal infections in adults. It is also effective for treating tinea capitis in children. In summary, it is used to improve various skin and nail fungal infections.

Dosage and Administration

Adult dosage

Administer terbinafine as 125 mg per dose twice daily or 250 mg per dose once daily. The duration of administration according to the condition is as follows: 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Usually administer for 6 weeks~3 months. In cases of infection of the fingernails or relatively small toenails, or in younger patients, the treatment period may be shortened to 3 months or less. A treatment period of 3 months is usually sufficient for toenail infections, but in some patients 6 months or longer may be required. The treatment period may be longer in patients with slow nail growth. For patients with creatinine clearance below 50 mL/min, reduce the daily dose by 1/2.

Children's dosage

Administer to children aged 2 years or older. Administration is not recommended for children under 2 years of age because there is no experience with use in this age group. Tinea capitis: 4 weeks 1) Body weight below 20 kg (under 5 years): Administer 62.5 mg per dose once daily. Because experience with use is limited, decide whether to administer by weighing the benefits and risks of treatment. 2) Body weight 20~40 kg (5~12 years): Administer 125 mg per dose once daily. 3) Body weight over 40 kg (over 12 years): Administer 250 mg per dose once daily.

Precautions

This medication is not recommended for patients with chronic or active liver disease. It is essential to check for liver disease before administration, and regular liver function tests should be conducted. If symptoms suggestive of liver dysfunction occur, inform a doctor immediately and discontinue the medication. Additionally, this drug can cause severe liver damage, such as hepatic failure; therefore, careful observation while performing regular liver function tests is necessary. This medication should not be administered to individuals who are hypersensitive to its ingredients, have chronic liver disease, blood disorders, severe renal failure, breastfeeding mothers, or infants under 2 years old. Particularly, since it contains lactose, patients with lactose intolerance should avoid taking it. Patients with impaired renal function, elderly individuals, and underweight children should use this medication with increased caution. Serious skin rashes or allergic reactions may occur rarely, and any skin changes should prompt immediate discontinuation of usage. During treatment, regular blood tests are required not only for liver function but also for any abnormal symptoms that may arise, and healthcare providers should be consulted promptly. This medication should only be used when the fungal infection has spread throughout the body, and caution is needed as dizziness and other side effects may occur during driving or operating machinery. Moreover, this medicine may interact with other drugs; therefore, if any other medications are being taken, this must be communicated to healthcare providers, and dosage adjustments might be necessary. For women who are pregnant or may become pregnant, the use of this drug should be carefully considered, and breastfeeding should be discontinued during treatment. Children and the elderly have different bodily functions, so when using this drug, benefits and risks must be thoroughly evaluated. In case of overdose, symptoms such as headache, nausea, abdominal pain, and dizziness may appear, so if such symptoms occur, immediate medical attention should be sought. This medication should be stored out of the reach of children and kept in a cool, dry place, away from direct sunlight.

Side effects

Liver failure, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, malaise, elevated γ-GTP, elevated AST/ALT, elevated LDH, elevated ALP, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, subcutaneous bleeding, leukopenia, anemia, rash, itching, photosensitivity reaction, mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, bullous dermatitis, psoriasis-like rash, exacerbation of psoriasis, hair loss, musculoskeletal reactions, joint pain, muscle pain, weakness, elevated CPK, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangitis, gastrointestinal symptoms, abdominal distension, dyspepsia, mild abdominal pain, diarrhea, gastric discomfort, thirst, glossitis, depression, anxiety, headache, taste disorder, dizziness, drowsiness, sensory abnormalities, sensory loss, decreased attention, insomnia, elevated BUN, increased frequency of urination, visual impairment, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, elevated total cholesterol, increased triglyceride levels, malaise, tongue discoloration, palpitations, edema, menstrual abnormalities, paralysis, systemic disorder, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, decreased vision, hearing loss, auditory impairment, vasculitis, permanent loss of smell, anosmia, hyposmia, eosinophilia, drug rash, pancreatitis, rhabdomyolysis, influenza-like illness, increased blood creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air exposure and kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

White to off-white round tablets

Package unit

30, 100 tablets

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.